SEC 13F Intelligence

Rhenman & Partners Asset Management AB / ABBV

Rhenman & Partners Asset Management AB’s Abbvie Inc Position

Does Rhenman & Partners Asset Management AB own Abbvie Inc (ABBV)? Yes — 71.6K shares worth $16M (+1.92% of its 13F portfolio) as of Q1 2026, down from 110.6K shares the prior filed quarter.

Position Value
$16M
Q1 2026
Shares
71.6K
% of Portfolio
+1.92%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $15MQ4 ’18Q1 ’19: $5MQ3 ’19: $13MQ4 ’19: $19MQ1 ’20: $25MQ1 ’20Q2 ’20: $29MQ3 ’20: $25MQ4 ’20: $54MQ1 ’21: $40MQ1 ’21Q2 ’21: $36MQ3 ’21: $38MQ4 ’21: $46MQ1 ’22: $32MQ1 ’22Q2 ’22: $29MQ3 ’22: $22MQ4 ’22: $21MQ1 ’23: $24MQ1 ’23Q2 ’23: $20MQ3 ’23: $22MQ4 ’23: $26MQ1 ’24: $35MQ1 ’24Q2 ’24: $32MQ3 ’24: $35MQ4 ’24: $22MQ1 ’25: $19MQ1 ’25Q2 ’25: $13MQ3 ’25: $30MQ4 ’25: $25MQ1 ’26: $16MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202671.6K$16M+1.92%
Q4 2025110.6K$25M+2.36%
Q3 2025130.4K$30M+3.34%
Q2 202569.4K$13M+1.63%
Q1 202588.7K$19M+2.13%
Q4 2024124.2K$22M+2.27%
Q3 2024177.0K$35M+2.84%
Q2 2024189.0K$32M+3.11%
Q1 2024189.5K$35M+3.27%
Q4 2023167.0K$26M+2.59%
Q3 2023150.0K$22M+2.41%
Q2 2023150.0K$20M+2.13%
Q1 2023152.0K$24M+2.64%
Q4 2022130.0K$21M+2.19%
Q3 2022149.6K$22M+2.29%
Q2 2022190.0K$29M+3.31%
Q1 2022195.0K$32M+3.12%
Q4 2021335.0K$46M+3.03%
Q3 2021355.0K$38M+2.69%
Q2 2021320.0K$36M+2.45%
Q1 2021368.0K$40M+2.78%
Q4 2020500.0K$54M+4.37%
Q3 2020280.0K$25M+2.18%
Q2 2020300.0K$29M+3.18%
Q1 2020330.0K$25M+3.52%
Q4 2019210.0K$19M+2.04%
Q3 2019170.0K$13M+1.61%
Q1 201960.0K$5M+0.57%
Q4 2018162.4K$15M+1.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of ABBV.